foxo4-dri protocol Targeting the FOXO4-p53 axis by retro-inverso peptide senolytic agents: a pharmacological strategy to mitigate brain aging and cognitive decline | Naunyn-Schmiedeberg's Archives of Pharmacology NewProduct: 0 AHK-Cu 100 mg Strength:3ml
SKU: 83653597550
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 16 - Sep 21